What is the appropriate inpatient treatment for an acute exacerbation of chronic obstructive pulmonary disease (COPD)?

Inpatient Treatment of COPD Exacerbation

For hospitalized patients with acute COPD exacerbation, administer oral corticosteroids (preferred over IV), antibiotics, inhaled short-acting bronchodilators, supplemental oxygen to maintain SpO2 88-92%, and initiate noninvasive ventilation immediately for those with acute or acute-on-chronic respiratory failure with respiratory acidosis. 1

Core Pharmacologic Interventions

Systemic Corticosteroids

• Use oral corticosteroids rather than intravenous formulations for hospitalized patients—they are equally effective with better feasibility 1
• Approximately 80% of hospitalized COPD exacerbation patients receive systemic corticosteroids in practice 2
• This represents a conditional recommendation from the ERS/ATS guideline based on evidence showing no superiority of IV over oral route 1

Antibiotics

• Administer antibiotics to hospitalized patients with COPD exacerbations 1, 3
• Nearly 92% of hospitalized patients receive antibiotics in real-world practice 2
• Antibiotics are particularly important for ICU patients, though optimal agent selection and duration for non-ICU patients requires clinical judgment 4
• The guideline provides a conditional recommendation supporting antibiotic use 1

Inhaled Bronchodilators

• Short-acting beta-agonists (SABAs) form the foundation of bronchodilator therapy during hospitalization 1, 2
• In practice, 72% receive single-product SABAs and 46% receive SABA-SAMA (short-acting muscarinic antagonist) combinations 2
• Only 5.5% of patients do not receive an SABA during hospitalization 2

Critical Non-Pharmacologic Interventions

Noninvasive Mechanical Ventilation (NIV)

• Strong recommendation: Use NIV for patients with acute or acute-on-chronic respiratory failure, particularly those with respiratory acidosis 1
• This is the only strong recommendation in the ERS/ATS guideline, reflecting robust evidence for mortality and morbidity reduction 1
• NIV should be considered early in patients with hypercapnic respiratory failure 4, 5

Oxygen Therapy

• Target SpO2 of 88-92% to avoid hypoxemia while preventing hyperoxia-induced hypercapnia 4
• Supplemental oxygen is recommended for hypoxemic patients 1
• High-flow nasal cannula (HFNC) oxygen therapy is emerging but requires further prospective studies 4

Discharge Planning and Rehabilitation

Pulmonary Rehabilitation

• Conditional recommendation: Initiate pulmonary rehabilitation within 3 weeks after hospital discharge 1
• Conditional recommendation against initiating pulmonary rehabilitation during hospitalization 1
• Early rehabilitation post-discharge is feasible, safe, and recommended when associated with standard treatment 4

Long-Acting Bronchodilators at Discharge

• Only 52% of patients receive long-acting bronchodilators (LABDs) before discharge in current practice, with 39% receiving LABAs 2
• This represents a significant gap, as maintenance therapy should be initiated before discharge 2
• Patients with primary COPD diagnosis and prior hospitalizations are more likely to receive LABDs 2

Common Pitfalls to Avoid

• Do not default to IV corticosteroids—oral formulations are equally effective and more practical 1
• Do not delay NIV in patients with respiratory acidosis—this is the intervention with the strongest evidence for mortality benefit 1
• Do not discharge patients without long-acting bronchodilator therapy—current practice shows only half receive this essential maintenance treatment 2
• Do not start pulmonary rehabilitation during hospitalization—wait until 3 weeks post-discharge for better outcomes 1

Adjunctive Care Components

• Venous thromboembolism prophylaxis 5
• Appropriate immunizations (pneumococcal vaccine) 5
• Smoking cessation counseling 5
• Ensure proper inhaler technique education before discharge 6